Skip to main content

Loperamide Side Effects

Last reviewed: December 2025

Overview

When used at recommended doses for short-term treatment of acute diarrhea, loperamide is generally well-tolerated. Most people experience few or no side effects. When side effects do occur at normal doses, they are typically mild.

However, it is critically important to never exceed recommended doses, as high doses of loperamide can cause serious and potentially fatal cardiac side effects.

Common Side Effects

The most frequently reported side effects of loperamide at recommended doses include:

Gastrointestinal Effects:

  • Constipation (most common)
  • Abdominal cramping or discomfort
  • Nausea
  • Gas or bloating
  • Dry mouth

General Effects:

  • Dizziness or lightheadedness
  • Drowsiness or fatigue
  • Headache

These effects are generally mild and resolve when the medication is discontinued.

Constipation

The most common side effect is constipation, which occurs because loperamide slows intestinal movement:

Managing constipation:

  • Use loperamide only until diarrhea is controlled, not longer
  • Do not exceed recommended doses
  • Discontinue loperamide once stools return to normal consistency
  • If severe constipation develops, stop taking loperamide and consult a healthcare provider

Prolonged use or excessive doses significantly increase constipation risk.

Less Common Side Effects

Some people may experience:

  • Stomach pain or discomfort
  • Vomiting
  • Rash or itching
  • Difficulty urinating
  • Loss of appetite
  • Weakness

If these effects are severe or persistent, discontinue use and consult a healthcare provider.

Serious Side Effects (Rare at Normal Doses)

While rare when loperamide is used properly, serious side effects can occur:

Severe Abdominal Symptoms:

  • Severe abdominal pain or swelling
  • Severe constipation
  • Bowel obstruction

Allergic Reactions:

  • Rash, hives, or itching
  • Swelling of face, lips, tongue, or throat
  • Difficulty breathing
  • Severe dizziness

Other Serious Effects:

  • Toxic megacolon (extremely rare, primarily in people with inflammatory bowel disease)
  • Severe drowsiness or loss of consciousness

If any serious side effects occur, stop using loperamide and seek immediate medical attention.

Cardiac Risks from High Doses

Critical Warning: Taking more than the recommended dose of loperamide can cause life-threatening heart rhythm problems.

Cardiac side effects from overdose or misuse:

  • QT interval prolongation (abnormal heart rhythm pattern)
  • Torsades de pointes (dangerous abnormal heart rhythm)
  • Ventricular arrhythmias
  • Cardiac arrest
  • Death

These cardiac effects have resulted in fatalities. Never exceed recommended doses.

Signs of cardiac problems may include:

  • Fainting or loss of consciousness
  • Rapid, irregular, or pounding heartbeat
  • Chest pain or discomfort
  • Severe dizziness
  • Shortness of breath

Seek emergency medical attention immediately if these symptoms occur.

Risk Factors for Side Effects

Certain factors increase the likelihood or severity of side effects:

  • The most significant risk factor for serious side effects
  • Even moderately exceeding recommendations can increase risks
  • Extremely high doses (seen in misuse) are potentially fatal

Liver Disease

People with liver disease may experience:

  • Higher drug levels in the bloodstream
  • Increased risk of side effects
  • Need for dose reduction or avoidance

Drug Interactions

Combining loperamide with certain medications increases risks:

  • Medications that affect heart rhythm
  • Drugs that inhibit liver enzymes (increasing loperamide levels)
  • Other medications that cause constipation

Inflammatory Bowel Disease

People with ulcerative colitis or Crohn’s disease may be at higher risk for:

  • Toxic megacolon (rare but serious)
  • Severe constipation
  • Worsening of underlying condition

Loperamide should only be used in these populations under medical supervision.

Dehydration

Using loperamide while dehydrated or without adequate fluid replacement can:

  • Worsen dehydration
  • Increase risk of complications
  • Cause electrolyte imbalances

Drug Interactions That Increase Side Effect Risk

Medications Affecting Heart Rhythm:

Combining loperamide with QT-prolonging medications significantly increases cardiac risk:

  • Certain antibiotics (erythromycin, azithromycin, fluoroquinolones)
  • Some antipsychotic medications
  • Certain antifungal medications (fluconazole, itraconazole)
  • Heart rhythm medications

Enzyme Inhibitors:

Medications that inhibit CYP3A4 or CYP2C8 enzymes can increase loperamide levels:

  • Certain antifungals (itraconazole, ketoconazole)
  • Some HIV medications (ritonavir)
  • Certain antibiotics
  • Grapefruit juice in large amounts

This increased level raises the risk of all side effects, especially cardiac effects.

Misuse and Abuse Risks

Some individuals have misused loperamide by taking extremely high doses in attempts to:

  • Achieve opioid-like euphoria
  • Self-treat opioid withdrawal symptoms
  • Manage chronic pain

This misuse is extremely dangerous:

  • High doses can cause fatal heart rhythm problems
  • Multiple deaths have been reported
  • No safe high-dose use exists
  • Does not effectively treat opioid withdrawal and is life-threatening

Never use loperamide for purposes other than treating diarrhea, and never exceed recommended doses.

Central Nervous System Effects

At normal doses, loperamide does not cross the blood-brain barrier significantly and does not cause opioid effects. However:

At extremely high doses (misuse):

  • May cross into the central nervous system
  • Can cause drowsiness, confusion, or loss of consciousness
  • May produce some opioid-like effects
  • Risk of overdose and death

This is another critical reason never to exceed recommended doses.

Effects in Special Populations

Children

Children may be more sensitive to loperamide’s effects:

  • Higher risk of central nervous system depression
  • Greater risk of severe constipation
  • Should only be used according to age and weight-specific guidelines
  • Never use in children under 2 for OTC treatment

Older Adults

Older adults should use loperamide cautiously:

  • May be more sensitive to side effects
  • Higher risk of constipation
  • Greater concern for dehydration
  • May have other medical conditions that increase risks

Pregnancy and Breastfeeding

Limited data exists on side effects in pregnancy. While loperamide appears relatively safe, pregnant individuals should consult healthcare providers.

Small amounts pass into breast milk. The risk to nursing infants appears low at normal doses, but nursing mothers should discuss use with a provider.

Minimizing Side Effects

To reduce the likelihood of side effects:

  • Use only at recommended doses
  • Do not exceed maximum daily limits
  • Discontinue once diarrhea is controlled
  • Do not use for more than 2 days without medical advice
  • Maintain adequate hydration
  • Avoid combining with interacting medications
  • Do not use if you have contraindications (bloody diarrhea, high fever, etc.)

When to Stop Using Loperamide

Discontinue loperamide and contact a healthcare provider if:

  • Diarrhea does not improve or worsens
  • You develop severe constipation or abdominal pain
  • Fever develops or increases
  • Blood appears in stools
  • Severe dizziness or heart palpitations occur
  • Allergic reaction symptoms develop
  • Any concerning side effects occur

Comparison with Other Treatments

Compared to Bismuth Subsalicylate:

Loperamide tends to:

  • Work more powerfully to stop diarrhea
  • Cause more constipation
  • Have more potential for serious misuse
  • Not provide antimicrobial benefits

Compared to Hydration Alone:

Loperamide:

  • Provides faster symptom relief
  • Does not replace fluids and electrolytes
  • Has more potential side effects
  • Should be combined with hydration, not used instead of it

Sources

This information is based on FDA safety communications, prescribing information, clinical safety data, and peer-reviewed medical literature.

Last reviewed: December 2025